PTH (1-84) prevents first vertebral fracture in postmenopausal women with osteoporosis: Results from the TOP study

被引:0
|
作者
Ettinger, MP
Greenspan, SL
Marriott, TB
Hanley, DA
Zanchetta, JR
Bone, HG
Lindsay, R
机构
[1] Radiant Res, Stuart, FL USA
[2] Univ Pittsburgh, Pittsburgh, PA USA
[3] NPS Pharmaceut, Salt Lake City, UT USA
[4] Univ Calgary, Calgary, AB, Canada
[5] IDIM, Buenos Aires, DF, Argentina
[6] Michigan Bone & Mineral Clin, Detroit, MI USA
[7] Helen Hayes Hosp, W Haverstraw, NY USA
来源
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 12期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:4103 / 4103
页数:1
相关论文
共 50 条
  • [1] Preventing the first vertebral fracture in postmenopausal women with low bone mass using PTH(1-84): Results from the TOP study.
    Greenspan, SL
    Bone, HG
    Marriott, TB
    Zanchetta, JR
    Ettinger, MP
    Hanley, DA
    Drezner, MK
    Miller, PD
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S56 - S56
  • [3] Treatment of postmenopausal women with osteoporosis with PTH(1-84) for 36 months: treatment extension study
    Zanchetta, Jose R.
    Bogado, Cesar E.
    Cisari, Carlo
    Aslanidis, Spyros
    Greisen, Hanna
    Fox, John
    Lems, Willem
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (11) : 2627 - 2633
  • [4] Safety and efficacy of PTH(1-84) at 18 and 24 months in women with postmenopausal osteoporosis receiving hormone therapy: Results from the POWER study
    Fogelman, I
    Christiansen, C
    Spector, T
    Fraser, W
    Fordham, J
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S21 - S22
  • [5] Efficacy of PTH (1-84) on vertebral and non-vertebral fractures in postmenopausal women with a high risk of vertebral fractures
    Roux, C.
    Martin, O. Illera
    Clausen, J.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S48 - S48
  • [6] Full length parathyroid hormone, PTH(1-84), for the treatment of severe osteoporosis in postmenopausal women
    Adami, Silvano
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (11) : 3259 - 3274
  • [7] Sequential treatment with full-length parathyroid PTH(1-84) of postmenopausal women with primary osteoporosis
    Felsenberg, D.
    Delmas, P.
    Hosking, D.
    Rizzoli, R.
    Brandi, M.
    Diaz-Curiel, M.
    Hyldstrup, L. H.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S126 - S126
  • [8] TERIPARATIDE AND PTH 1-84 IN THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH BISPHOSPHONATE-RESISTANT OSTEOPOROSIS: A CASE-CONTROL STUDY
    Loriggiola, L.
    Camozzi, V. I.
    Schiavon, L.
    Salva, M.
    Basso, S. M. M.
    Lumachi, F.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2015, 26 : S193 - S194
  • [9] POSTMENOPAUSAL OSTEOPOROTIC WOMEN TREATED WITH PTH 1-84: EVALUATION OF OUTCOMES
    Pastore, Renato
    Chioma, Laura
    Borboni, Patrizia
    Vancieri, Giuseppe
    Mentuccia, Daniela
    Frajese, Giovanni Vanni
    [J]. OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 395 - 395
  • [10] Acute and chronic effects of PTH(1-84) on heart rate and cardiac repolarization in postmenopausal women with osteoporosis.
    Mason, J. W.
    Moon, T. E.
    Heusner, J. J.
    Morris, S.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S299 - S299